España
Acceder
Cotización de Acadia Pharmaceuticals (ACAD) hoy en tiempo real
Análisis técnico y gráfico histórico de Acadia Pharmaceuticals
Análisis fundamental y estadísticas clave de Acadia Pharmaceuticals
Ficha de Acadia Pharmaceuticals (ACAD)
| Ticker | ACAD |
|---|---|
| ISIN | US0042251084 |
| Sector | Atención sanitaria |
| Mercado | NASDAQ |
Análisis financiero de Acadia Pharmaceuticals
Resumen financiero e información corporativa de Acadia Pharmaceuticals
Ratios de valoración: PER, EV/EBITDA y métricas de Acadia Pharmaceuticals
Márgenes de rentabilidad y Cash Flow de Acadia Pharmaceuticals
BPA, Dividendos y Valor Contable: Métricas por acción de Acadia Pharmaceuticals
Solvencia y deuda: Análisis del balance de Acadia Pharmaceuticals
Ratios de liquidez y Test Ácido: Capacidad de pago de Acadia Pharmaceuticals
Invertir en Acadia Pharmaceuticals en 2026: Preguntas frecuentes
¿Qué es Acadia Pharmaceuticals?
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psychosis, and negative symptoms of schizophrenia; T...
¿En qué sector opera Acadia Pharmaceuticals?
Acadia Pharmaceuticals opera en el sector Healthcare, industria Biotechnology.
